Slate Path Capital LP - Q2 2019 holdings

$2.23 Billion is the total value of Slate Path Capital LP's 30 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 28.6% .

 Value Shares↓ Weighting
SNAP SellSNAP INCcl a$270,413,000
+11.1%
18,910,000
-14.4%
12.13%
-38.5%
GDX SellVANECK VECTORS ETF TRgold miners etf$25,560,000
-76.3%
1,000,000
-79.2%
1.15%
-86.9%
WPM SellWHEATON PRECIOUS METALS CORP$3,748,000
-20.5%
155,000
-21.7%
0.17%
-56.0%
GPRE SellGREEN PLAINS INC$3,040,000
-70.1%
282,000
-53.8%
0.14%
-83.5%
TDW SellTIDEWATER INC NEW$2,583,000
-41.4%
110,000
-42.1%
0.12%
-67.5%
BMA ExitBANCO MACRO SAspon adr b$0-43,000
-100.0%
-0.16%
ARNA ExitARENA PHARMACEUTICALS INC$0-215,000
-100.0%
-0.78%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARTER COMMUNICATIONS INC N30Q3 202315.2%
ALNYLAM PHARMACEUTICALS INC30Q3 20208.9%
UNITED STATES STL CORP NEW24Q3 202311.4%
NEW YORK TIMES CO23Q3 202310.9%
VANECK VECTORS ETF TR21Q3 202319.5%
PAN AMERN SILVER CORP21Q3 20237.6%
CUE BIOPHARMA INC17Q3 20231.3%
BARRICK GOLD CORPORATION16Q4 202015.7%
MOSAIC CO NEW15Q4 202116.8%
MEDICINES CO15Q4 201912.2%

View Slate Path Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Slate Path Capital LP Q2 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cue Biopharma, Inc.February 14, 20232,402,4555.6%
Stitch Fix, Inc.February 14, 2023? ?
Cyclerion Therapeutics, Inc.January 13, 20237,157,60116.5%
Zimmer Energy Transition Acquisition Corp.February 14, 20222,000,0005.8%
5:01 Acquisition Corp.February 11, 2022500,0005.8%
Hippo Holdings Inc.February 11, 2022350,0000.1%
Warner Music Group Corp.February 11, 20223,134,7792.6%
Reinvent Technology Partners ZFebruary 16, 20211,750,0007.6%

View Slate Path Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-01-22
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G2023-02-14
13F-HR2023-02-14
SC 13G2023-01-13
SC 13G2022-11-18

View Slate Path Capital LP's complete filings history.

Compare quarters

Export Slate Path Capital LP's holdings